REAL-WORLD OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND SUBSTANCE ABUSE DISORDERS TREATED WITH GLECAPREVIR/PIBRENTASVIR FOR 8 WEEKS: A POOLED ANALYSIS OF MULTINATIONAL POST-MARKETING OBSERVATIONAL STUDIES

被引：0

作者：

Rizzardini, Giuliano ^{[1
]}

Gschwantler, Michael ^{[2
]}

Bourgeois, Stefan ^{[3
]}

Mullhaupt, Beat ^{[4
,5
]}

Mazur, Wlodzimierz ^{[6
]}

Bondin, Mark ^{[7
]}

Zhang, Zhenzhen ^{[7
]}

Marra, Fiona ^{[8
]}

Veitsman, Ella ^{[9
]}

Mimidis, Konstantinos ^{[10
]}

Marques, Nuno ^{[11
]}

Foucher, Juliette ^{[12
]}

机构：

[1] Asst Fatebenefratelli Sacco, Div Infect Dis 1, Milan, Italy

[2] Wilhelminenspital Stadt Wien, Dept Internal Med 4, Vienna, Austria

[3] Stuivenberg Zna, Antwerp, Belgium

[4] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland

[5] Univ Zurich, Zurich, Switzerland

[6] Med Univ Silesia, Clin Dept Infect Dis, Katowice, Poland

[7] Abbvie Inc, N Chicago, IL USA

[8] Univ Liverpool, Hepatol Drug Interact Grp, Liverpool, Merseyside, England

[9] Rambam Hlth Care Campus, Liver Unit, Haifa, Israel

[10] Democritus Univ Thrace, Sch Med, Dept Internal Med 1, Xanthi, Greece

[11] Hosp Garcia Orta Epe, Infect Dis Serv, Almada, Portugal

[12] Hop Haut Leveque, Pessac, France

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

929

引用

页码：568A / 569A

页数：2

共 47 条

[31] Drug-Drug Interaction Potential of Glecaprevir/Pibrentasvir Based on Real-World Use of Co-Medications in Patients with Chronic Hepatitis C Virus Infection: Data from the German Hepatitis C Registry (DHC-R)
Vermehren, Johannes
Boeker, Klaus H. W.
Bondin, Mark I.
Mauss, Stefan
Pathil, Anita
Klinker, Hartwig
Lutz, Thomas
Marra, Fiona
Hettinger, Jan
Kleine, Henning
Buggisch, Peter
HEPATOLOGY, 2018, 68 : 409A - 410A
[32] Improved clinical outcomes in patients treated with natalizumab for at least 8 years - real-world data from a Swedish national post-marketing surveillance study (IMSE 1)
Kagstrom, S.
Falt, A.
Forsberg, L.
Berglund, A.
Hillert, J.
Nilsson, P.
Dahle, C.
Svenningsson, A.
Lycke, J.
Landtblom, A. -M.
Burman, J.
Sundstrom, P.
Martin, C.
Gunnarsson, M.
Piehl, F.
Olsson, T.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 763 - 764
[33] Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan
Wang, Szu Jen
Huang, Chung-Feng
Chang, Te Sheng
Lo, Ching Chu
Hung, Chao Hung
Huang, Chien Wei
Chong, Lee Won
Cheng, Pin Nan
Yeh, Ming Lun
Peng, Cheng Yuan
Cheng, Chien Yu
Huang, Jee Fu
Bair, Ming Jong
Lin, Chih Lang
Yang, Chi Chieh
Kuo, Hsing Tao
Hsieh, Tsai Yuan
Lee, Tzong Hsi
Lee, Pei Lun
Wu, Wen Chih
Lin, Chih Lin
Su, Wei Wen
Yang, Sheng Shun
Wang, Chia Chi
Hu, Jui Ting
Mo, Lein Ray
Chen, Chun Ting
Huang, Yi Hsiang
Chang, Chun Chao
Huang, Chia Sheng
Chen, Guei Ying
Kao, Chien Neng
Tai, Chi Ming
Liu, Chun Jen
Lee, Mei Hsuan
Tsai, Pei Chien
Dai, Chia Yen
Kao, Jia Horng
Lin, Han Chieh
Chuang, Wang Long
Tseng, Kuo Chih
Chen, Chi Yi
Wang, Shu-Chi
Yu, Ming-Lung
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2025, 41 (02):
[34] HIGHER HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C (CHC) PATIENTS AFTER HEPATITIS C VIRUS (HCV) CURE COMPARED TO TREATED CHRONIC HEPATITIS B (CHB): RESULTS FROM A MULTINATIONAL REAL-WORLD COHORT OF PATIENTS WITH CIRRHOSIS
Park, Jiyoon
Tran, Sally
Ogawa, Eiichi
Huang, Chung-Feng
Toyoda, Hidenori
Chen, Chien Hung
Yeh, Ming-Lun
Tseng, Cheng-Hao
Hsu, Yao-Chun
Kawashima, Keigo
Preda, Carmen
Istratescu, Doina
Yasuda, Satoshi
Nozaki, Akito
Chuma, Makoto
Oh, Hyunwoo
Shim, Jae-Jun
Jeong, Soung Won
An, Jihyun
Ahn, Sang Bong
Kim, Sung Eun
Yoon, Eileen
Lee, Han Ah
Kim, Hyoung Su
Cho, Yong Kyun
Uojima, Haruki
Trinh, Huy
Atsukawa, Masanori
Itokawa, Norio
Okubo, Tomomi
Abe, Hiroshi
Lee, Dong Hyun
Jun, Mi Jung
Landis, Charles
Liu, Joanne
Enomoto, Masaru
Watanabe, Tsunamasa
Ji, Fanpu
Wang, Wenjun
Yu, Li
Xie, Qing
Fukunishi, Shinya
Asai, Akira
Yokohama, Keisuke
Ishikawa, Toru
Liu, Li
Li, Junyi
Takahashi, Hirokazu
Inoue, Kaori
Eguchi, Yuichiro
HEPATOLOGY, 2022, 76 : S377 - S379
[35] A LARGE REAL WORLD, LONG TERM SAFETY STUDY OF PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES TREATED WITH INFLIXIMAB BIOSIMILAR (CT-P13): POOLED ANALYSIS OF FOUR GLOBAL POST-MARKETING STUDIES
Baek, Kyungmin
Lee, Yoon Jee
Lee, Sujin
Kim, Houng
Lee, Seulgi
Park, Jeong Eun
Lee, SangJoon
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 718 - 719
[36] Impact of a simplified diagnosis-monitoring strategy on Glecaprevir/Pibrentasvir (G/P) treatment initiation and response in patients with chronic hepatitis C virus (HCV) infection receiving opioid substitute therapy in Israel-a real world evidence
Zuckerman, Eli
Azulay, Orly
JOURNAL OF HEPATOLOGY, 2024, 80 : S834 - S835
[37] Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
Liu, C. -H.
Yang, S. -S.
Sun, H. -Y.
Liu, C. -J.
Liu, W. -C.
Su, T. -H.
Yang, H. -C.
Hong, C. -M.
Tseng, T. -C.
Chen, P. -J.
Chen, D. -S.
Hung, C. -C.
Kao, J. -H.
JOURNAL OF HEPATOLOGY, 2018, 68 : S266 - S266
[38] Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
Liu, Chen-Hua
Huang, Yi-Jie
Yang, Sien-Sing
Chang, Chung-Hsin
Yang, Sheng-Shun
Sun, Hsin-Yun
Liu, Chun-Jen
Liu, Wen-Chun
Su, Tung-Hung
Yang, Hung-Chih
Hong, Chun-Ming
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Hung, Chien-Ching
Kao, Jia-Horng
SCIENTIFIC REPORTS, 2018, 8
[39] Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
Chen-Hua Liu
Yi-Jie Huang
Sien-Sing Yang
Chung-Hsin Chang
Sheng-Shun Yang
Hsin-Yun Sun
Chun-Jen Liu
Wen-Chun Liu
Tung-Hung Su
Hung-Chih Yang
Chun-Ming Hong
Tai-Chung Tseng
Pei-Jer Chen
Ding-Shinn Chen
Chien-Ching Hung
Jia-Horng Kao
Scientific Reports, 8
[40] Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry
Younossi, Zobair M.
Yu, Ming-Lung
El-Kassas, Mohamed
Esmat, Gamal
Fernandez, Marlen I. Castellanos
Buti, Maria
Papatheodoridis, Georgios
Yilmaz, Yusuf
Isakov, Vasily
Duseja, Ajay
Mendez-Sanchez, Nahum
Hamid, Saeed
Gordon, Stuart C.
Romero-Gomez, Manuel
Chan, Wah-Kheong
Ong, Janus P.
Younossi, Issah
Lam, Brain
Ziayee, Mariam
Nader, Fatema
Racila, Andrei
Henry, Linda
Stepanova, Maria
JOURNAL OF VIRAL HEPATITIS, 2022, 29 (11) : 1015 - 1025

← 1 2 3 4 5 →